Atlas Venture Advisors, Inc. Long-Term Concentrated

CIK: 0001767432 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 6, 2019

Total Value ($000): $241,605 (100.0% shares, 0.0% debt)

Holdings (6)

— CARBON BLACK INC 68.0%

Value ($000) $164,242 Shares 9,823,103 Est. Cost $13.42 Unrealized —

— TRANSLATE BIO INC 20.5%

Value ($000) $49,535 Shares 3,922,008 Est. Cost $7.50 Unrealized —

BCYC BICYCLE THERAPEUTICS PLC 5.7%

Value ($000) $13,709 Shares 1,362,696 Est. Cost $10.06 Unrealized —

— MIRAGEN THERAPEUTICS INC 2.7%

Value ($000) $6,442 Shares 3,142,580 Est. Cost $3.03 Unrealized —

— ZAFGEN INC 1.7%

Value ($000) $4,172 Shares 3,506,207 Est. Cost $4.95 Unrealized —

SNAP SNAP INC 1.5%

Value ($000) $3,505 Shares 245,076 Est. Cost $6.50 Unrealized +88.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	CARBON BLACK INC	9,823,103	$164,242	68.0%	$13.42	—	COM	14081R103
—	TRANSLATE BIO INC	3,922,008	$49,535	20.5%	$7.50	—	COM	89374L104
BCYC	BICYCLE THERAPEUTICS PLC	1,362,696	$13,709	5.7%	$10.06	—	SPONSORED ADS	088786108
—	MIRAGEN THERAPEUTICS INC	3,142,580	$6,442	2.7%	$3.03	—	COM	60463E103
—	ZAFGEN INC	3,506,207	$4,172	1.7%	$4.95	—	COM	98885E103
SNAP	SNAP INC	245,076	$3,505	1.5%	$6.50	+88.0%	CL A	83304A106